Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa

Authors: Vieux Momeme Mokoli, Ernest Kiswaya Sumaili, François Bompeka Lepira, Fiston Ikwa Ndol Mbutiwi, Jean Robert Rissassy Makulo, Justine Busanga Bukabau, Patrick Parmba Izeidi, Jeannine Losa Luse, Stéphane Kalambay Mukendi, Désiré Kulimba Mashinda, Nazaire Mangani Nseka

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Decreased residual urine volume (RUV) is associated with higher mortality in hemodialysis (HD). However, few studies have examined RUV in patients on HD in Sub-Saharan Africa. The aim of this study was to identify predictors of RUV among incident hemodialysis patients in Kinshasa.

Methods

This historical cohort study enrolled 250 patients with ESRD undergoing hemodialysis between January 2007 and July 2013 in two hemodialysis centers in Kinshasa. RUV were collected over 24 h at the initiation of HD and 6 and 12 months later during the interdialytic period. We compared the baseline characteristics of the patients according to their initial RUV (≤ 500 ml/day vs >  500 ml/day) using Student’s t, Mann-Whitney U and Chi2 tests. Linear mixed-effects models were used to search for predictors of decreased RUV by adding potentially predictive baseline covariates of the evolution of RUV to the effect of time: age, sex, diabetes mellitus, hypertension, diastolic blood pressure, diuretics, angiotensin conversion enzyme inhibitors (ACEI), angiotensin receptor blockers, hypovolemia, chronic tubulointerstitial nephropathy, left ventricular hypertrophy and initial hemodialysis characteristic. A value of p < 0.05 was considered the threshold of statistical significance.

Results

The majority of hemodialysis patients were male (68.8%, sex ratio 2.2), with a mean age of 52.5 ± 12.3 years. The population’s RUV decreased with time, but with a slight deceleration. The mean RUV values were 680 ± 537 ml/day, 558 ± 442 ml/day and 499 ± 475 ml/day, respectively, at the initiation of HD and at 6 and 12 months later. The use of ACEI at the initiation of HD (beta coefficient 219.5, p < 0.001) and the presence of chronic tubulointerstitial nephropathy (beta coefficient 291.8, p = 0.007) were significantly associated with RUV preservation over time. In contrast, the presence of left ventricular hypertrophy at the initiation of HD was significantly associated with decreased RUV over time (beta coefficient − 133.9, p = 0.029).

Conclusions

Among incident hemodialysis patients, the use of ACEI, the presence of chronic tubulointerstitial nephropathy and reduced left ventricular hypertrophy are associated with greater RUV preservation in the first year of dialysis.
Literature
1.
go back to reference Sumaili EK, Krzesinski JM, Cohen EP, Nseka NM. Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital. Nephrol Ther. 2010;6(4):232–9.CrossRefPubMed Sumaili EK, Krzesinski JM, Cohen EP, Nseka NM. Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital. Nephrol Ther. 2010;6(4):232–9.CrossRefPubMed
2.
go back to reference Bargman JM. The CANUSA study and the importance of residual kidney function in dialysis patients. Kidney Int. 2010;77(10):931. author reply 931-932CrossRefPubMed Bargman JM. The CANUSA study and the importance of residual kidney function in dialysis patients. Kidney Int. 2010;77(10):931. author reply 931-932CrossRefPubMed
3.
go back to reference Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010;339(5):453–6.CrossRefPubMed Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians. Am J Med Sci. 2010;339(5):453–6.CrossRefPubMed
4.
go back to reference Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. J Am Soc Nephrol. JASN 2016;27(12):3758-68. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients. J Am Soc Nephrol. JASN 2016;27(12):3758-68.
5.
go back to reference Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556–64.PubMed Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556–64.PubMed
6.
go back to reference Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000;20(4):429–38.PubMed Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000;20(4):429–38.PubMed
7.
go back to reference Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C, Chen J, Kalantar-Zadeh K. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol. 2014;40(2):140–50.CrossRefPubMed Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C, Chen J, Kalantar-Zadeh K. Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol. 2014;40(2):140–50.CrossRefPubMed
8.
go back to reference Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003;23(3):276–83.PubMed Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003;23(3):276–83.PubMed
9.
go back to reference Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001;16(11):2207–13.CrossRefPubMed Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001;16(11):2207–13.CrossRefPubMed
10.
go back to reference Kim JK, Kim SG, Kim MG, Kim SE, Kim SJ, Kim HJ, Song YR. Left ventricular diastolic dysfunction as a predictor of rapid decline of residual renal function in patients with peritoneal dialysis. J Am Soc Echocardiogr. 2012;25(4):411–20.CrossRefPubMed Kim JK, Kim SG, Kim MG, Kim SE, Kim SJ, Kim HJ, Song YR. Left ventricular diastolic dysfunction as a predictor of rapid decline of residual renal function in patients with peritoneal dialysis. J Am Soc Echocardiogr. 2012;25(4):411–20.CrossRefPubMed
11.
go back to reference Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–53.CrossRefPubMed Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–53.CrossRefPubMed
12.
go back to reference Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, Tsai TJ, Wu KD. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton, Vic). 2009;14(1):59–64.CrossRef Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, Tsai TJ, Wu KD. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton, Vic). 2009;14(1):59–64.CrossRef
13.
go back to reference Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83(5):949–58.CrossRefPubMedPubMedCentral Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013;83(5):949–58.CrossRefPubMedPubMedCentral
14.
go back to reference Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, Chen J, Mathew AT, Kovesdy CP, Mehrotra R, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident Dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(2):256–65.CrossRefPubMedPubMedCentral Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, Chen J, Mathew AT, Kovesdy CP, Mehrotra R, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident Dialysis patients: a cohort study. Am J Kidney Dis. 2016;68(2):256–65.CrossRefPubMedPubMedCentral
15.
go back to reference Lang SM, Bergner A, Topfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. 2001;21(1):52–7.PubMed Lang SM, Bergner A, Topfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int. 2001;21(1):52–7.PubMed
16.
go back to reference National Kidney Foundation. KDOQI clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S2–90. National Kidney Foundation. KDOQI clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis. 2006;48(Suppl 1):S2–90.
17.
go back to reference Yang PY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH, Chen KH, Ho TC. Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Ren Fail. 2009;31(6):423–30.CrossRefPubMed Yang PY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH, Chen KH, Ho TC. Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Ren Fail. 2009;31(6):423–30.CrossRefPubMed
18.
go back to reference Xydakis D, Papadogiannakis A, Sfakianaki M, Kostakis K, Stylianou K, Petrakis I, Ergini A, Voskarides K, Dafnis E. Residual renal function in hemodialysis patients: the role of angiotensin-converting enzyme inhibitor in its preservation. ISRN nephrology. 2013;2013:184527.CrossRefPubMed Xydakis D, Papadogiannakis A, Sfakianaki M, Kostakis K, Stylianou K, Petrakis I, Ergini A, Voskarides K, Dafnis E. Residual renal function in hemodialysis patients: the role of angiotensin-converting enzyme inhibitor in its preservation. ISRN nephrology. 2013;2013:184527.CrossRefPubMed
19.
go back to reference Cravedi P, Remuzzi G, Ruggenenti P. Targeting the renin angiotensin system in dialysis patients. Semin Dial. 2011;24(3):290–7.CrossRefPubMed Cravedi P, Remuzzi G, Ruggenenti P. Targeting the renin angiotensin system in dialysis patients. Semin Dial. 2011;24(3):290–7.CrossRefPubMed
20.
go back to reference Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis outcomes and practice pattern study (DOPPS). Am J Kidney Dis. 2007;49(3):426–31.CrossRefPubMed Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis outcomes and practice pattern study (DOPPS). Am J Kidney Dis. 2007;49(3):426–31.CrossRefPubMed
21.
go back to reference Coronel F, Perez Flores I. Factors related to loss of residual renal function in peritoneal dialysis. Nefrologia. 2008;28(Suppl 6):39–44.PubMed Coronel F, Perez Flores I. Factors related to loss of residual renal function in peritoneal dialysis. Nefrologia. 2008;28(Suppl 6):39–44.PubMed
22.
go back to reference Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, Wanner C, Dekker FW. Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis. 2009;53(6):1014–23.CrossRefPubMed Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, Wanner C, Dekker FW. Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis. 2009;53(6):1014–23.CrossRefPubMed
23.
go back to reference Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial. 2004;17(3):196–201.CrossRefPubMed Chandna SM, Farrington K. Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial. 2004;17(3):196–201.CrossRefPubMed
24.
go back to reference Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands cooperative study on the adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–70.CrossRefPubMed Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands cooperative study on the adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–70.CrossRefPubMed
25.
go back to reference McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002;61(1):256–65.CrossRefPubMed McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int. 2002;61(1):256–65.CrossRefPubMed
27.
go back to reference Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016;90(2):262–71.CrossRefPubMedPubMedCentral Mathew AT, Fishbane S, Obi Y, Kalantar-Zadeh K. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016;90(2):262–71.CrossRefPubMedPubMedCentral
28.
go back to reference Truijen J, Bundgaard-Nielsen M, van Lieshout JJ. A definition of normovolaemia and consequences for cardiovascular control during orthostatic and environmental stress. Eur J Appl Physiol. 2010;109(2):141–57.CrossRefPubMedPubMedCentral Truijen J, Bundgaard-Nielsen M, van Lieshout JJ. A definition of normovolaemia and consequences for cardiovascular control during orthostatic and environmental stress. Eur J Appl Physiol. 2010;109(2):141–57.CrossRefPubMedPubMedCentral
29.
go back to reference Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254–66.CrossRefPubMedPubMedCentral Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015;5(4):254–66.CrossRefPubMedPubMedCentral
30.
go back to reference Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail. 2011;17(7):527–32.CrossRefPubMed Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail. 2011;17(7):527–32.CrossRefPubMed
31.
go back to reference Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis. 2010;56(2):348–58.CrossRefPubMedPubMedCentral Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis. 2010;56(2):348–58.CrossRefPubMedPubMedCentral
32.
go back to reference Nechita AM, Radulescu D, Peride I, Niculae A, Bratu O, Ferechide D, Ciocalteu A, Checherita IA, Mischianu D. Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis. J Med Life. 2015;8(3):371–7.PubMedPubMedCentral Nechita AM, Radulescu D, Peride I, Niculae A, Bratu O, Ferechide D, Ciocalteu A, Checherita IA, Mischianu D. Determining factors of diuresis in chronic kidney disease patients initiating hemodialysis. J Med Life. 2015;8(3):371–7.PubMedPubMedCentral
33.
go back to reference Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrol. 2014;15:101.CrossRefPubMedPubMedCentral Jensen JM, Mose FH, Kulik AE, Bech JN, Fenton RA, Pedersen EB. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls. BMC Nephrol. 2014;15:101.CrossRefPubMedPubMedCentral
34.
go back to reference Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–72.CrossRefPubMed Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–72.CrossRefPubMed
35.
go back to reference Vilar E, Farrington K. Emerging importance of residual renal function in end-stage renal failure. Semin Dial. 2011;24(5):487–94.CrossRefPubMed Vilar E, Farrington K. Emerging importance of residual renal function in end-stage renal failure. Semin Dial. 2011;24(5):487–94.CrossRefPubMed
36.
go back to reference Costea AC, Costea DO, David C, Grasa CN. Role of ACE inhibitors in the management of arterial hypertension of hemodyalised patients. Rev Med Chir Soc Med Nat Iasi. 2010;114(1):29–33.PubMed Costea AC, Costea DO, David C, Grasa CN. Role of ACE inhibitors in the management of arterial hypertension of hemodyalised patients. Rev Med Chir Soc Med Nat Iasi. 2010;114(1):29–33.PubMed
37.
go back to reference Ryckelynck JP, Goffin E, Verger C. Maintaining residual renal function in patients on dialysis. Nephrol Ther. 2013;9(6):403–7.CrossRefPubMed Ryckelynck JP, Goffin E, Verger C. Maintaining residual renal function in patients on dialysis. Nephrol Ther. 2013;9(6):403–7.CrossRefPubMed
38.
go back to reference Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000;57(5):1803–17.CrossRefPubMed Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000;57(5):1803–17.CrossRefPubMed
39.
go back to reference Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergstrom J, Palmblad J, Heimburger O, Cederholm T. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med. 1999;246(5):503–7.CrossRefPubMed Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergstrom J, Palmblad J, Heimburger O, Cederholm T. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med. 1999;246(5):503–7.CrossRefPubMed
40.
go back to reference Oguz EG, Gursoy GK, Yayar O, Yildirim T, Cimen T, Bulut C, Eser B, Canbakan B, Yeter E, Ayli MD. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy? Ren Fail. 2016;38(8):1180–6.CrossRefPubMed Oguz EG, Gursoy GK, Yayar O, Yildirim T, Cimen T, Bulut C, Eser B, Canbakan B, Yeter E, Ayli MD. Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy? Ren Fail. 2016;38(8):1180–6.CrossRefPubMed
42.
go back to reference Yang Y, Wang R, Li MX, Xing Y, Li WG. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Int J Cardiol. 2016;219:350–7.CrossRefPubMed Yang Y, Wang R, Li MX, Xing Y, Li WG. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on left ventricular mass index and ejection fraction in hemodialysis patients: a meta-analysis with trial sequential analysis of randomized controlled trials. Int J Cardiol. 2016;219:350–7.CrossRefPubMed
43.
go back to reference McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL. Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis. 2016;68(5s1):S5–s14.CrossRefPubMed McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL. Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis. 2016;68(5s1):S5–s14.CrossRefPubMed
44.
go back to reference Schiffl H, Lang SM, Fischer R. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol. 2013;45(5):1389–96.CrossRefPubMed Schiffl H, Lang SM, Fischer R. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy. Int Urol Nephrol. 2013;45(5):1389–96.CrossRefPubMed
Metadata
Title
Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa
Authors
Vieux Momeme Mokoli
Ernest Kiswaya Sumaili
François Bompeka Lepira
Fiston Ikwa Ndol Mbutiwi
Jean Robert Rissassy Makulo
Justine Busanga Bukabau
Patrick Parmba Izeidi
Jeannine Losa Luse
Stéphane Kalambay Mukendi
Désiré Kulimba Mashinda
Nazaire Mangani Nseka
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0865-x

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue